Name: Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: Care management intervention strategies
Published: 2026-09-21T21:42:40-04:00

Product information and disease description Place of product in therapy Approaches to treatment

Care management intervention strategies

6 evidence topics · 3 sources

Recommended laboratory monitoring

“Liver chemistries should be performed at the time of diagnosis and at least yearly thereafter ( Table 1 ).” (opens the source at this quote in a new tab)
“Because of the risk of iron deficiency and anemia, it is reasonable for patients to have an annual CBC and iron panel ( Table 1 ).” (opens the source at this quote in a new tab)
“Routine screening for vitamin D deficiency and supplementation as per population guidelines are recommended ( Table 1 ).” (opens the source at this quote in a new tab)

Genotype-directed iron repletion

“Iron repletion is indicated for XLP patients with iron deficiency because the addition of iron in the context of normal FECH function is expected to improve erythrocyte protoporphyrin levels.” (opens the source at this quote in a new tab)

Hepatoprotective measures and immunization

“Avoidance of excessive alcohol intake is recommended for all patients. Furthermore, immunization against hepatitis A and B is recommended.” (opens the source at this quote in a new tab)

Skin surveillance during melanocortin 1 receptor agonist therapy

“A regular full body skin examination (twice yearly) is recommended to monitor all nevi and other skin abnormalities.” (opens the source at this quote in a new tab)

Perioperative light filtering

“In patients undergoing surgery of prolonged duration, such as liver transplantation, light filters that limit transmission of the wavelengths 340-470 nm (i.e., acrylate yellow filter) are recommended.” (opens the source at this quote in a new tab)

Documentation supporting school and workplace accommodation

“Supportive care can include a document and/or medical alert card from the porphyria centre describing the medical condition, as well as the consequences of light exposure and the need for light protection. With these documents, patients can inform not only their peers, teachers and colleagues but also their health care providers, enabling a better understanding of the required adaptations.” (opens the source at this quote in a new tab)